UMIN000049949
Effects of alkalization therapy for hepatocellular carcinoma: a retrospective study
Japanese Society on Inflammation and Metabolism in Cancer·University Hospital Medical Information NetworkRecruitment Completed
Study focus
- Disease/Condition
- Hepatocellular carcinoma
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Japanese Society on Inflammation and Metabolism in Cancer
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Nov 01, 2022
- End date
- N/A
ICD-10 classifications
Malignant neoplasm: HepatoblastomaMalignant neoplasm: Liver cell carcinomaMalignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver, unspecifiedMalignant neoplasm: Hepatic flexure
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000049949
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000049949 through Pure Global AI's free database. This phase not specified trial is sponsored by Japanese Society on Inflammation and Metabolism in Cancer and is currently Recruitment Completed. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.